Skip to main content
SpringerLink
Log in

Antiphospholipidsyndrom

Antiphospholipid syndrome

  • Leitthema: Meilensteine in der Rheumatologie: 75 Bände Innovation
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Wassermann A, Neisser A, Bruck C (1906) Eine serodiagnostische Reaktion bei Syphilis. Dtsch Med Wochenschr 32:745–789

    Article  Google Scholar 

  2. Pangborn MD (1941) A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 48:484–486

    Article  CAS  Google Scholar 

  3. Moore JE, Mohr CF (1952) Biologically false positive serologic test for syphilis. JAMA 150:467–473

    Article  CAS  Google Scholar 

  4. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman LE, Wallace SL (1971) Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21:643–648

    Google Scholar 

  5. Tan EM, Cohen AS, Fries JF (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  CAS  PubMed  Google Scholar 

  6. Laurell AB, Nilsson IM (1957) Hypergammaglubulinaemia, circulating anticoagulant and biologic false positive Wassermann reaction. J Lab Clin Med 49:694–707

    CAS  PubMed  Google Scholar 

  7. Feinstein DJ, Rapaport SJ (1972) Acquired inhibitors of blood coagulation. In: Spaet TN (Hrsg) Prog Haemostas Thromb, 1. Aufl. Grune and Stratton, New York, S 75–95

    Google Scholar 

  8. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA (1963) Thrombosis in SLE despite circulating anticoagulants. J Lab Clin Med 9:416–430

    Google Scholar 

  9. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV (1986) Thrombosis, recurrent fetal loss and Thrombocytopenia. Arch Intern Med 146:2153–2156

    Article  CAS  PubMed  Google Scholar 

  10. Harris EN, Hughes GRV, Gharavi AE (1987) The antiphospholipid antibody syndrome. J Rheumatol 13(Suppl):210

    Google Scholar 

  11. Hughes GRV (1993) The antiphospholipid syndrome: ten years on. Lancet 342:341–344

    Article  CAS  PubMed  Google Scholar 

  12. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311

    Article  CAS  PubMed  Google Scholar 

  13. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot DEPG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306

    Article  CAS  PubMed  Google Scholar 

  14. Moore GW (2014) Recent guidelines and recommendations for laboratory detection of lupus anticoagulants. Semin Thromb Hemost 40(2):163–171

    Article  CAS  PubMed  Google Scholar 

  15. Mujic F, Cuadrado MJ, Lloyd M, Khamashta MA, Page G, Hughes GR (1995) Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 22(8):1589–1592

    CAS  PubMed  Google Scholar 

  16. Ratzinger F, Lang M, Belik S, Jilma-Stohlawetz P, Schmetterer KG, Haslacher H, Perkmann T, Quehenberger P (2016) Lupus-anticoagulant testing at NOAC trough levels. Thromb Haemost 116(2). PubMed PMID: 27075441 (Epub ahead of print)

  17. Dunn AS, Kaboli P, Halfdanarson T, Chan H, Hubert R, Rosen S, White RH (2005) Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder? Thromb Haemost 94(3):548–554

    CAS  PubMed  Google Scholar 

  18. Specker C (2015) Antiphospholipidsyndrom. Z Rheumatol 74(3):191–198

    Article  CAS  PubMed  Google Scholar 

  19. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 376(9751):1498–1509. doi:10.1016/S0140-6736(10)60709-X.

    Article  CAS  PubMed  Google Scholar 

  20. Vianna JL, Khamashta MA, Ordi-Ros J et al (1994) Comparison of the primary and secondary Antiphospholipid Syndrome: A european multicenter study of 114 patients. Am J Med 96:3–9

    Article  CAS  PubMed  Google Scholar 

  21. Meroni PL, Rivolta R, Ghidoni P (1991) Histopathological findings in cases of systemic lupus erythematosus-associated antiphospholipid syndrome. Clin Rheumatol 10:211–214

    Article  CAS  PubMed  Google Scholar 

  22. Hughson MD, McCarty GA, Brumback RA (1995) Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Patol 26:716–724

    Article  CAS  Google Scholar 

  23. Cervera RR-PI, Espinosa G (2014) Catastrophic antiphospholipid syndrome: task force report summary. Lupus 23(12):1283–1285 (on behalf of the Task Force on Catastrophic Antiphospholipid Syndrom) doi:10.1177/0961203314540764.

    Article  PubMed  Google Scholar 

  24. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD (2002) A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 41(8):924–929

    Article  CAS  Google Scholar 

  25. Giron-Gonzalez JA, del, Rodriguez C, Rodriguez-Martorell J, Serrano A (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31(8):1560–1567

    PubMed  Google Scholar 

  26. Brey RL, Escalante A (1998) Neurological manifestations of antiphospholipid antibody syndrome. Lupus 7(Suppl 2):S67–74

    Article  PubMed  Google Scholar 

  27. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, Groot PG de, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46(4):1019–1027

    Article  PubMed  Google Scholar 

  28. Cervera R, Bucciarelli S (2009) Plas í n MA et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun 32:240–245

    Article  CAS  PubMed  Google Scholar 

  29. Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Marchetti T, Balducchi JP, Marès P, Gris JC (2014) Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 123(3):404–413

    Article  CAS  PubMed  Google Scholar 

  30. Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A (2011) Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 50(9):1684–1689

    Article  CAS  Google Scholar 

  31. Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR, Kim MY, Salmon JE (2016) Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med 3(1):e000131

    Article  PubMed  PubMed Central  Google Scholar 

  32. Empson M, Lassere M, Craig J, Scott J (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 18(2):15846641

    Google Scholar 

  33. Fischer-Betz R, Specker C (2003) Antiphospholipid-Antikörper und Schwangerschaft. Akt Rheumatol 28(3):131–137. doi:10.1055/s-2003-40444

    Article  Google Scholar 

  34. Lim W, Crowther MA, Eikelboom JW (2006) Management of antiphospholipid antibody syndrome. A systematic review. JAMA 295:1050–1057

    Article  CAS  PubMed  Google Scholar 

  35. Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics: 2011 update. A report from the American Heart Association. Circulation 123(4):e18–e209

    Article  PubMed  Google Scholar 

  36. Ruffatti A, Del Ross T, Ciprian M, Bertero MT, Sciascia S, Scarpato S, Montecucco C, Rossi S, Caramaschi P, Biasi D, Doria A, Rampudda M, Monica N, Fischetti F, Picillo U, Brucato A, Salvan E, Vittorio P, Meroni P, Tincani A (2011) Antiphospholipid Syndrome Study Group of Italian Society of Rheumatology. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis 70(6):1083–1086

    Article  PubMed  Google Scholar 

  37. Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F, De Micheli V, Gresele P, Tonello M, Ghirarduzzi A, Bison E, Denas G, Banzato A, Padayattil JS, Iliceto S (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118(17):4714–4718

    Article  CAS  PubMed  Google Scholar 

  38. Mok CC, Tang SSK, To CH et al (2005) Incidence and risk factors of thromboembolism systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 52(9):2774–2782

    Article  PubMed  Google Scholar 

  39. Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, Alam Z, Carey JL (1997) IgG anticardiolipin antibody titer 〉 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke 28(9):1660–1665

    Article  CAS  PubMed  Google Scholar 

  40. Bermas BL, Schur PH, Kaplan AA (2014) Treatment of the antiphospholipid syndrome. In: UpToDate, Pisetsky DS (Hrsg) UpToDate, Waltham, MA

    Google Scholar 

  41. Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM (2009) Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 61(1):29–36

    Article  PubMed  Google Scholar 

  42. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R, Erkan D, Krilis S, Machin S, Pengo V, Pierangeli S, Tektonidou M, Khamashta M (2011) Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 20(2):206–218

    Article  CAS  PubMed  Google Scholar 

  43. Erkan D, Patel S, Nuzzo M, Gerosa M, Meroni PL, Tincani A, Lockshin MD (2008) Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) 47(Suppl 3):iii23–iii7

    Google Scholar 

  44. Danowski A, Rego J, Kakehasi AM, Funke A, Carvalho JF, Lima IV, Souza AW, Levy RA (2013) Guidelines for the treatment of antiphospholipid syndrome. Rev Bras Reumatol 53(2):184–192

    Article  PubMed  Google Scholar 

  45. Schröder JO, Zeuner RA, Specker C (2011) Systemischer Lupus erythematodes und Antiphospholipid-Syndrom. Akt Rheumatol 35(1):24–32. doi:10.1055/s-0030-1248295

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Rheumatologie & Klinische Immunologie, Krankenhaus St. Josef, Universitätsklinikum Essen, Propsteistr. 2, 45239, Essen, Deutschland

    C. Specker

Authors
  1. C. Specker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Specker.

Ethics declarations

Interessenkonflikt

C. Specker gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

U. Müller-Ladner, Bad Nauheim

H.-M. Lorenz, Heidelberg

M. Schneider, Düsseldorf

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Specker, C. Antiphospholipidsyndrom. Z Rheumatol 75, 570–574 (2016). https://doi.org/10.1007/s00393-016-0153-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-016-0153-8

Search

Navigation